Unless somehow they're suggesting getting 9/10 tre
Post# of 148169
Quote:
The study found that 88% of participants receiving lenacapavir (n=21/24) experienced at least 0.5 log (66%) reduction in HIV-1 viral load by the end of 14 days of functional monotherapy as compared with 17% on placebo.
Additionally, the lenacapavir group achieved a statistically significant greater mean change in viral load versus placebo.